Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In situ quantification of aberrant p53 in colorectal neoplasia.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals - 1 Jan 2000

Smith Steven Jay, Neugut Alfred, Heitjan Daniel, Forde Kenneth, Holt Peter, Santella Regina M, Jiin-Chyuan Luo, Carney Walter, Ward Llewelyn, Brandt-Rauf Paul W

Abstract excerpt

Aberrant p53 protein accumulation was measured immunohistologically in 342 colorectal paraffin-embedded tissue sections from 115 patients (24 with adenocarcinoma, 59 with adenoma and 32 'hospital controls'). Subjective scoring was compared with quantitative cell imaging, including dichotomous (p5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenoma
Share to Antigens, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Immunohistochemistry

Share to Severity of Illness Index

Share to Survival Analysis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12944180
DOI: 10.1080/1354750031000138676

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12944180-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In situ quantification of aberrant p53 in colorectal neoplasia.PMID 12944180Read ↗

Quantification and characterization of total cellular p53 protein in colorectal cancer.Semantic proximity Read ↗

p53 protein accumulation and p53 gene mutation in colorectal cancer.Semantic proximity Read ↗

p53 genetic alterations, protein expression and autoantibodies in human colorectal carcinoma: A comparative study.Semantic proximity Read ↗

p53 alterations are associated with improved prognosis in distal colonic carcinomas.Semantic proximity Read ↗

Expression of p53 protein in invasive colorectal carcinomas of different histologic types.Semantic proximity Read ↗

Enzyme-linked immunosorbent assay for p53 in gastrointestinal malignancy: comparison with immunohistochemistry.Semantic proximity Read ↗

p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.Semantic proximity Read ↗

p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinomaSemantic proximity Read ↗

Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.Semantic proximity Read ↗

p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer.Semantic proximity Read ↗

Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.Semantic proximity Read ↗

Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.